U.S. racial and ethnic participation in global clinical trials by therapeutic areas

• Published in: Journal of clinical pharmacy and therapeutics Vol. 46; no. 6; pp. 1576 - 1581
• Main Authors: Lolic, Milena, Araojo, Richardae, Okeke, Melvyn, Temple, Robert
• Format: Journal Article
• Language: English
• Published: England John Wiley & Sons, Inc 01.12.2021; John Wiley and Sons Inc
• Subjects: African Americans - statistics & numerical data; American Indians or Alaska Natives - statistics & numerical data; Asians - statistics & numerical data; Census; Clinical trials; Clinical Trials as Topic - statistics & numerical data; controlled clinical trial; Epidemiology; Ethnic and Racial Minorities - statistics & numerical data; FDA approval; Gastroenterology; Hispanic Americans; Hispanic or Latino - statistics & numerical data; Humans; Infectious diseases; Medical imaging; Multiculturalism & pluralism; Original; population analysis; rate; Research Subjects - statistics & numerical data; United States; Whites - statistics & numerical data; United States; United States > US; controlled clinical trial; population analysis; rate

What is known and objective The discussion about health equity in the United States frequently involves concerns over racial and ethnic minority under‐representation in clinical trials and particularly in trials conducted in support of product approvals. The FDA has long worked to encourage diverse...